medicineScienceTelehealth Giant Hims Wants to Test Every Dude for Low TestosteroneBy Kate KnibbsScienceThe Science Behind the Nobel-Winning Technology That Controls Neurons With LightBy Fernanda GonzálezScienceSome Pancreatic Cells Are Just One Genetic Tweak Away From Treating DiabetesBy Jorge GarayScienceHe Won the Nobel Prize for Protein Design. Now He Uses AI to Create Molecules Not Found in NatureBy Jorge GarayScienceCockroach Milk, How to Blow Your Nose, and Mosquito Printers: The Ig Nobels of 2026By Jorge GarayThe Big StoryInside the Perimenopause Industrial ComplexBy Kate KnibbsBusinessAI Has Human Doctors Asking: What’s Left for Us?By Steven LevyScienceA New Device Eases One of the Most Annoying Parts of Routine PhysicalsBy Daisuke TakimotoCulture‘They’re Fucking a Lot of People’: 7-OH Users Brace for DEA BanBy Manisha KrishnanScienceMeasles Is Becoming So Common That Treatments May Soon Be NeededBy Emily MullinScienceAn FDA Panel Just Endorsed These Unproven PeptidesBy Emily MullinThe Big Story‘The Child Is Terrified’: Measles Doctors Speak OutBy Amy Maxmen, KFF Health NewsCulturePete Hegseth’s Plan for ‘High T’ Troops Is a Junk-Science Fever DreamBy Miles KleeScienceScientists’ Side Hustle? Using AI and Quantum Computing to Generate New PeptidesBy Isabella WardCultureInfluencers Are Promoting $50 Straws They Claim Will Protect Against Electromagnetic RadiationBy Ej Dickson ScienceThe FDA Ruled That Zyn Pouches Are Safer Than Cigarettes. That Doesn’t Mean They’re SafeBy Megan Tomos CultureThe DEA Plans to Ban Opioid-Like Kratom Compound 7-OHBy Manisha KrishnanScienceA Startup Is Using Special Polymers to Better Help Nerves HealBy Isabella WardSciencePseudoscientific Cancer ‘Treatment’ Involves Gassing Naked People in Plastic Bags With BleachBy David GilbertScienceThe Sperm-Maxxing Bros Are Actually Onto SomethingBy Gabriela GalvinGearCVS Is Switching to Aluminum Pill BottlesBy Boone AshworthCultureThe Kratom Civil War Is Heating Up, and MAHA Has Picked a SideBy Mattha BusbyScienceI Was Scammed Buying GLP-1s Online. I’m Not AloneBy John SemleyScienceLongevity Startup Doses First Human in Bid to Reverse Age-Related Sight LossBy Isabella WardMore Stories
